《肝细胞癌合并肝静脉或下腔静脉癌栓多学科诊治中国专家共识(2019版)》解读

Interpretation of Chinese expert consensus on multidisciplinary diagnosis and yreatment of hepatocellular carcinoma with hepatic vein or inferior vena cava tumor thrombus

肝细胞癌合并肝静脉或下腔静脉癌栓(HVTT/IVCTT)是肝癌的一种特殊类型,发生率为1.4%~4.9%,疾病进展快、预后差。中国医师协会肝癌专业委员会基于国内外HVTT/IVCTT相关研究获得的循证医学证据,并结合我国的临床实践,制订了《肝细胞癌合并肝静脉或下腔静脉癌栓多学科诊治中国专家共识(2019版)》。该共识针对肝细胞癌合并HVTT/IVCTT的临床表现、诊断和分型,外科治疗,辅助治疗以及其他局部、区域性和系统性治疗提出了较详细的初步指导意见,对规范和统一我国肝细胞癌合并HVTT/IVCTT病人的治疗将起到积极地推动作用。

Hepatic vein or inferior vena cave tumor thrombus(HVTT/IVCTT)is a special type of hepatocellular carcinoma(HCC).The incidence of HVTT/IVCTT is 1.4%to 4.9%of all HCC patients.HVTT/IVCTT progresses rapidly and has a very poor prognosis.Based on the evidence-based medical evidence obtained from the international studies on HVTT/IVCTT in recent years,as well as the clinical practice in our country,the expert group of the Chinese Association of Liver Cancer and Chinese Medical Doctor Association formulate the"Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with hepatic vein or inferior vena cave tumor thrombus(2019 edition)",which has systematically addressed the clinical manifestations,diagnostic methods,staging,surgical and adjuvant treatment,and other local,regional and systemic treatments of HCC with HVTT/IVCTT.This consensus is designed to standardize and popularize the diagnosis and multidisciplinary treatment of HVTT/IVCTT to improve overall prognoses of the disease.